Home › Nierkanker (niercelcarcinoom) › Maryland › Baltimore
Nierkanker (niercelcarcinoom) klinische studies in Baltimore, MD
10 studies voor Nierkanker (niercelcarcinoom) zoeken deelnemers op locaties in en rond Baltimore (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
RekruterenFase 1
- Research Site, Baltimore
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Mercy Medical Center, Baltimore
- Sinai Hospital of Baltimore, Baltimore
- MedStar Franklin Square Medical Center/Weinberg Cancer Institute, Baltimore
- en nog 2
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruterenFase 1
- Exelixis Clinical Site #14, Baltimore
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
RekruterenFase 1/2
- Johns Hopkins Hospital, Baltimore
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RekruterenFase 3
- University of Maryland/Greenebaum Cancer Center, Baltimore
- UM Baltimore Washington Medical Center/Tate Cancer Center, Glen Burnie · 9 mijl verwijderd
A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)
RekruterenFase 3
- Greater Baltimore Medical Center ( Site 0145), Baltimore
Study of 111In-XYIMSR-01 SPECT/CT in Patients With Metastatic Clear Cell Renal Cell
RekruterenFase 1
- Johns Hopkins University, Baltimore
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)
RekruterenFase 1/2
- Johns Hopkins University (Data Collection Only), Baltimore
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RekruterenFase 1
- Johns Hopkins Hospital /ID# 254056, Baltimore
Study of Olaparib in Metastatic Renal Cell Carcinoma Patients With DNA Repair Gene Mutations
RekruterenFase 2
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore
Nierkanker (niercelcarcinoom) studies in andere steden
- Houston, TX35 studies
- New York City, NY27 studies
- Nashville, TN23 studies
- Dallas, TX23 studies
- St. Louis, MO23 studies
- Los Angeles, CA20 studies
- Boston, MA16 studies
- Baldwin Park, CA16 studies
- Pittsburgh, PA15 studies
- Philadelphia, PA15 studies
- Queens, NY15 studies
- Rochester, MN14 studies
Andere studies in Baltimore
- Niet-kleincellige longkanker60 studies
- Borstkanker47 studies
- Prostaatkanker43 studies
- Longkanker40 studies
- Kanker (alle vormen)37 studies
- Aldermeesklierkanker31 studies
- Colorectale kanker31 studies
- Metastatische kanker28 studies
- Obesitas26 studies
- Blasenkanker24 studies
- Hartfalen24 studies
- Eierstokkanker22 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.